Russ Middaugh

Dr. Middaugh’s research is focused on understanding the changes in physicochemical properties that accompany the loss of biological activity of biopharmaceuticals and vaccines, and on developing new analytical techniques to monitor these changes at the molecular level. A detailed understanding of the causes and molecular mechanisms of instability will guide the design of more potent and stable biopharmaceutical and vaccine dosage forms. He holds a B.S. degree from the University of California, Santa Cruz, and a Ph.D. from Cornell. He completed a post-doctoral fellowship at the University of Minnesota.